Alzheimer\'s Research & Therapy

Alzheimer's disease & dementia

New alteration in the brains of people with Alzheimer's discovered

Despite the important advances in research in recent years, the etiopathogenesis of Alzheimer's disease is still not fully clarified. One of the key questions is to decipher why the production of beta amyloid, the protein ...

Neuroscience

Bilingualism acts as a cognitive reserve factor against dementia

The conclusions of a study carried out by Víctor Costumero, as the first author, Marco Calabria and Albert Costa (died in 2018), members of the Speech Production and Bilingualism (SPB) group at the Cognition and Brain Center ...

Alzheimer's disease & dementia

Biomarker indicating neurodegeneration identified in the eye

A new study led by Boston Medical Center researchers indicates a well-known biomarker that serves as a marker for earlier diagnosis of neurodegenerative diseases is now detectable in the eye. Neurofilament light chain, a ...

Alzheimer's disease & dementia

Tracing the impact of amyloid beta in mild cognitive impairment

The amount of amyloid β (Aβ) in the brains of people with mild cognitive impairment (MCI) is contributing to early memory loss, and increases with severity of symptoms, finds a study in BioMed Central's open access journal ...

Alzheimer's disease & dementia

Would you take a free predictive test for Alzheimer's disease?

Three-quarters of people aged 65 and over in the US would take a test telling them they were going to develop Alzheimer's disease if such a test existed, according to research published in the open access journal Alzheimer's ...

Alzheimer's disease & dementia

Blocking the effects of amyloid b in Alzheimer's disease

During Alzheimer's disease, 'plaques' of amyloid beta (Ab) and tau protein 'tangles' develop in the brain, leading to the death of brain cells and disruption of chemical signaling between neurons. This leads to loss of memory, ...

page 3 from 5